Hagersten, Sweden

Torbjörn Gräslund

This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Affibody Ab. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Torbjörn Gräslund. Retrieved from https://idiyas.com/inventor/torbjörn-gräslund

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Torbjörn Gräslund: A Focus on Polypeptides

Introduction

Torbjörn Gräslund is a renowned inventor located in Hägersten, Sweden. He holds an impressive portfolio with four patents to his name, showcasing his commitment to advancing biomedical science through his inventive capabilities.

Latest Patents

One of Torbjörn's notable contributions is a class of engineered polypeptides that exhibit a binding affinity for the neonatal Fc receptor (FcRn). His patent details this FcRn binding polypeptide, characterized by the sequence EXXXAXXEIRWLPNL XXXQRXAFIXXLXX. This innovation is not just about the polypeptide itself; it emphasizes its potential use as an agent to modify pharmacokinetic and pharmacodynamic properties, making it a promising therapeutic agent.

Additionally, Torbjörn has contributed to the field with a patent related to neonatal Fc receptor binding dimers. This patent describes dimers of engineered polypeptides that bind to FcRn with a higher capacity than any single monomer unit. This enhanced binding allows for improved pharmacokinetic and pharmacodynamic manipulation, further establishing its therapeutic potential.

Career Highlights

Torbjörn Gräslund currently works at Affibody AB, a company recognized for its innovative approaches within the biotechnology sphere. His work at this organization has been pivotal in expanding the application of polypeptides in medical therapies, contributing significantly to the biotechnology landscape.

Collaborations

Throughout his career, Torbjörn has collaborated with talented coworkers, including Caroline Ekblad and Elin Gunneriusson. These partnerships have fostered an environment of innovation, enhancing the research and development efforts at Affibody AB.

Conclusion

Torbjörn Gräslund’s contributions to the field of biomedicine through his patents on engineered polypeptides highlight his role as an influential inventor. His work not only advances scientific knowledge but also opens up new avenues for therapeutic application, reinforcing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…